Congrats to Julia Byrska, who received the Cecil Alport Gold Award for Best Presentation at the 2026 International Workshop on Alport Syndrome in Budapest. 🏅
A fantastic recognition for her work on a urinary peptidomic classifier for Alport syndrome.
#AlportSyndrome #KidneyResearch #MSCA
A fantastic recognition for her work on a urinary peptidomic classifier for Alport syndrome.
#AlportSyndrome #KidneyResearch #MSCA
September 9, 2026 at 8:36 AM
Congrats to Julia Byrska, who received the Cecil Alport Gold Award for Best Presentation at the 2026 International Workshop on Alport Syndrome in Budapest. 🏅
A fantastic recognition for her work on a urinary peptidomic classifier for Alport syndrome.
#AlportSyndrome #KidneyResearch #MSCA
A fantastic recognition for her work on a urinary peptidomic classifier for Alport syndrome.
#AlportSyndrome #KidneyResearch #MSCA
Julia Byrska presented her work on a urinary peptidomic classifier for the non-invasive diagnosis of Alport syndrome at the 2026 International Workshop on Alport Syndrome in Budapest.
Read more:
🔗 www.projectpicked.eu/news-and-eve...
#AlportSyndrome #Peptidomics #KidneyResearch #MSCA
Read more:
🔗 www.projectpicked.eu/news-and-eve...
#AlportSyndrome #Peptidomics #KidneyResearch #MSCA
September 8, 2026 at 9:36 AM
Julia Byrska presented her work on a urinary peptidomic classifier for the non-invasive diagnosis of Alport syndrome at the 2026 International Workshop on Alport Syndrome in Budapest.
Read more:
🔗 www.projectpicked.eu/news-and-eve...
#AlportSyndrome #Peptidomics #KidneyResearch #MSCA
Read more:
🔗 www.projectpicked.eu/news-and-eve...
#AlportSyndrome #Peptidomics #KidneyResearch #MSCA
Doctoral Candidate Julia Byrska presented her research on urinary peptide biomarkers for the non-invasive diagnosis of Alport syndrome at the 8th Cardiovascular, Renal and Metabolic Diseases Area Meeting.
Read more:
🔗 www.projectpicked.eu/news-and-eve...
#KidneyResearch #AlportSyndrome #Biomarkers
Read more:
🔗 www.projectpicked.eu/news-and-eve...
#KidneyResearch #AlportSyndrome #Biomarkers
July 28, 2026 at 8:43 AM
Doctoral Candidate Julia Byrska presented her research on urinary peptide biomarkers for the non-invasive diagnosis of Alport syndrome at the 8th Cardiovascular, Renal and Metabolic Diseases Area Meeting.
Read more:
🔗 www.projectpicked.eu/news-and-eve...
#KidneyResearch #AlportSyndrome #Biomarkers
Read more:
🔗 www.projectpicked.eu/news-and-eve...
#KidneyResearch #AlportSyndrome #Biomarkers
🚨New GN in 10🎙️
Think Alport's only affects males 🧬? Think again!
@kdjhaveri.bsky.social & Koyal Jain provide a comprehensive clinical overview of hereditary nephritis—aka Alport syndrome.
🎧 Listen here: share.transistor.fm/s/434d7408
#AlportSyndrome #ISGD #GNin10 @tobias-b-huber.bsky.social
Think Alport's only affects males 🧬? Think again!
@kdjhaveri.bsky.social & Koyal Jain provide a comprehensive clinical overview of hereditary nephritis—aka Alport syndrome.
🎧 Listen here: share.transistor.fm/s/434d7408
#AlportSyndrome #ISGD #GNin10 @tobias-b-huber.bsky.social
June 19, 2026 at 3:40 PM
🚨New GN in 10🎙️
Think Alport's only affects males 🧬? Think again!
@kdjhaveri.bsky.social & Koyal Jain provide a comprehensive clinical overview of hereditary nephritis—aka Alport syndrome.
🎧 Listen here: share.transistor.fm/s/434d7408
#AlportSyndrome #ISGD #GNin10 @tobias-b-huber.bsky.social
Think Alport's only affects males 🧬? Think again!
@kdjhaveri.bsky.social & Koyal Jain provide a comprehensive clinical overview of hereditary nephritis—aka Alport syndrome.
🎧 Listen here: share.transistor.fm/s/434d7408
#AlportSyndrome #ISGD #GNin10 @tobias-b-huber.bsky.social
Throwback Thursday to when the RaDaR team presented #AlportSyndrome data at the FDA in Washington DC.
David Pitcher, Dr Katie Wong & Prof Daniel Gale took part in discussions on using surrogate endpoints to accelerate clinical trials - a key step toward new treatments.
🔗https://ow.ly/lKNe50XJBsj
David Pitcher, Dr Katie Wong & Prof Daniel Gale took part in discussions on using surrogate endpoints to accelerate clinical trials - a key step toward new treatments.
🔗https://ow.ly/lKNe50XJBsj
February 5, 2026 at 11:45 AM
Throwback Thursday to when the RaDaR team presented #AlportSyndrome data at the FDA in Washington DC.
David Pitcher, Dr Katie Wong & Prof Daniel Gale took part in discussions on using surrogate endpoints to accelerate clinical trials - a key step toward new treatments.
🔗https://ow.ly/lKNe50XJBsj
David Pitcher, Dr Katie Wong & Prof Daniel Gale took part in discussions on using surrogate endpoints to accelerate clinical trials - a key step toward new treatments.
🔗https://ow.ly/lKNe50XJBsj
📢 Incidental findings of autosomal dominant #AlportSyndrome in reproductive carrier screening offer a unique chance to protect kidney health early 🧬
Discover how a small step can lead to a significant impact ⬇️ #Genetics #KidneyHealth
www.nature.com/articles/s41...
Discover how a small step can lead to a significant impact ⬇️ #Genetics #KidneyHealth
www.nature.com/articles/s41...
From screening to strategy: Clinical implications of COL4A3/COL4A4 variants found in reproductive genetic testing - European Journal of Human Genetics
European Journal of Human Genetics - From screening to strategy: Clinical implications of COL4A3/COL4A4 variants found in reproductive genetic testing
www.nature.com
January 5, 2026 at 8:15 AM
📢 Incidental findings of autosomal dominant #AlportSyndrome in reproductive carrier screening offer a unique chance to protect kidney health early 🧬
Discover how a small step can lead to a significant impact ⬇️ #Genetics #KidneyHealth
www.nature.com/articles/s41...
Discover how a small step can lead to a significant impact ⬇️ #Genetics #KidneyHealth
www.nature.com/articles/s41...
🌍 RaDaR team members presented #AlportSyndrome data at FDA headquarters in Washington DC.
Discussions focused on accelerating clinical trials using surrogate endpoints – a key step toward developing treatments for this rare kidney disease.
Read more: https://ow.ly/lKNe50XJBsj
Discussions focused on accelerating clinical trials using surrogate endpoints – a key step toward developing treatments for this rare kidney disease.
Read more: https://ow.ly/lKNe50XJBsj
December 19, 2025 at 10:00 AM
🌍 RaDaR team members presented #AlportSyndrome data at FDA headquarters in Washington DC.
Discussions focused on accelerating clinical trials using surrogate endpoints – a key step toward developing treatments for this rare kidney disease.
Read more: https://ow.ly/lKNe50XJBsj
Discussions focused on accelerating clinical trials using surrogate endpoints – a key step toward developing treatments for this rare kidney disease.
Read more: https://ow.ly/lKNe50XJBsj
#Bayer has started a phase 2a trial of an antibody that it hopes could provide a targeted, potentially disease-modifying therapy for #Alportsyndrome, a rare, genetic disease that leads to #chronickidneydisease (CKD).
pharmaphorum.com/news/bayer-t...
pharmaphorum.com/news/bayer-t...
December 4, 2025 at 10:40 AM
#Bayer has started a phase 2a trial of an antibody that it hopes could provide a targeted, potentially disease-modifying therapy for #Alportsyndrome, a rare, genetic disease that leads to #chronickidneydisease (CKD).
pharmaphorum.com/news/bayer-t...
pharmaphorum.com/news/bayer-t...
Also my favorite poster companion 💜
@asnpublications.bsky.social
@alportuk.bsky.social
#ASN #KidneyWeek #AlportSyndrome
@asnpublications.bsky.social
@alportuk.bsky.social
#ASN #KidneyWeek #AlportSyndrome
November 7, 2025 at 4:57 PM
Also my favorite poster companion 💜
@asnpublications.bsky.social
@alportuk.bsky.social
#ASN #KidneyWeek #AlportSyndrome
@asnpublications.bsky.social
@alportuk.bsky.social
#ASN #KidneyWeek #AlportSyndrome
Thanks to NIDDK for funding this work! #AlportSyndrome @alportuk.bsky.social @alportalliance.bsky.social
Mouse Alport podocytes are susceptible to AAV9 transduction in vivo
doi.org/10.1016/j.kint.2025.09.027
#MedSky #NephSky
@jeffminerphd.bsky.social @washunephrology.bsky.social @washumedicine.bsky.social
doi.org/10.1016/j.kint.2025.09.027
#MedSky #NephSky
@jeffminerphd.bsky.social @washunephrology.bsky.social @washumedicine.bsky.social
November 4, 2025 at 6:27 PM
Thanks to NIDDK for funding this work! #AlportSyndrome @alportuk.bsky.social @alportalliance.bsky.social
Unfolding the potential—chemical chaperones in #Alportsyndrome
doi.org/10.1016/j.kint.2025.07.006
Original article: doi.org/10.1016/j.kint.2025.05.016
#KICommentary #NephSky #MedSky #CKD
doi.org/10.1016/j.kint.2025.07.006
Original article: doi.org/10.1016/j.kint.2025.05.016
#KICommentary #NephSky #MedSky #CKD
October 17, 2025 at 2:09 PM
Unfolding the potential—chemical chaperones in #Alportsyndrome
doi.org/10.1016/j.kint.2025.07.006
Original article: doi.org/10.1016/j.kint.2025.05.016
#KICommentary #NephSky #MedSky #CKD
doi.org/10.1016/j.kint.2025.07.006
Original article: doi.org/10.1016/j.kint.2025.05.016
#KICommentary #NephSky #MedSky #CKD
💡 #biobank.cy
Watch a discussion of the new scientific findings and the promising prospects from the study on the treatment of a rare inherited kidney disease—#AlportSyndrome.
🔗 Watch it here: buff.ly/2qVRzgx
🔗 Read more: buff.ly/WezkYvk
🧵 2/7
Watch a discussion of the new scientific findings and the promising prospects from the study on the treatment of a rare inherited kidney disease—#AlportSyndrome.
🔗 Watch it here: buff.ly/2qVRzgx
🔗 Read more: buff.ly/WezkYvk
🧵 2/7
Ανακάλυψη για τη θεραπεία του συνδρόμου Alport από την ομάδα του Biobank.cy & την Ιατρική Σχολή | biobank.cy Center of Excellence in Biobanking and Biomedical Research
Pavlos Ioannou PhD Cand., and Christofer Odiatis, Research Project Leader biobank.cy join the University of Cyprus channel to discuss the new scientific findings and the promising prospects from the…
buff.ly
September 18, 2025 at 7:06 AM
💡 #biobank.cy
Watch a discussion of the new scientific findings and the promising prospects from the study on the treatment of a rare inherited kidney disease—#AlportSyndrome.
🔗 Watch it here: buff.ly/2qVRzgx
🔗 Read more: buff.ly/WezkYvk
🧵 2/7
Watch a discussion of the new scientific findings and the promising prospects from the study on the treatment of a rare inherited kidney disease—#AlportSyndrome.
🔗 Watch it here: buff.ly/2qVRzgx
🔗 Read more: buff.ly/WezkYvk
🧵 2/7
The AlportSyndFndn's #AlportSyndrome Research & Regulatory Workshop brought together 35 experts - including
@jeffminerphd.bsky.social - dedicated to advancing therapeutic development for this rare #genetic kidney disease. #Nephrology See more: nephrology.wustl.edu/jeffrey-mine...
@jeffminerphd.bsky.social - dedicated to advancing therapeutic development for this rare #genetic kidney disease. #Nephrology See more: nephrology.wustl.edu/jeffrey-mine...
Jeffrey Miner Among Leading Experts at Alport Syndrome Research & Regulatory Workshop - Division of Nephrology
Jeffrey Miner, PhD, FASN, Eduardo and Judith Slatopolsky Professor of Medicine in Nephrology at Washington University, was among the 35 workshop participants of the Alport Syndrome Research & Regulato...
nephrology.wustl.edu
August 4, 2025 at 5:58 PM
The AlportSyndFndn's #AlportSyndrome Research & Regulatory Workshop brought together 35 experts - including
@jeffminerphd.bsky.social - dedicated to advancing therapeutic development for this rare #genetic kidney disease. #Nephrology See more: nephrology.wustl.edu/jeffrey-mine...
@jeffminerphd.bsky.social - dedicated to advancing therapeutic development for this rare #genetic kidney disease. #Nephrology See more: nephrology.wustl.edu/jeffrey-mine...
Join Alport Warriors!
A supportive FB group for those living with Alport Syndrome.
www.facebook.com/groups/17746...
Because no one should face this alone.
#AlportWarriors #AlportSyndrome #RareDiseaseCommunity #SupportNetwork #AlportUK
A supportive FB group for those living with Alport Syndrome.
www.facebook.com/groups/17746...
Because no one should face this alone.
#AlportWarriors #AlportSyndrome #RareDiseaseCommunity #SupportNetwork #AlportUK
July 28, 2025 at 9:08 AM
Join Alport Warriors!
A supportive FB group for those living with Alport Syndrome.
www.facebook.com/groups/17746...
Because no one should face this alone.
#AlportWarriors #AlportSyndrome #RareDiseaseCommunity #SupportNetwork #AlportUK
A supportive FB group for those living with Alport Syndrome.
www.facebook.com/groups/17746...
Because no one should face this alone.
#AlportWarriors #AlportSyndrome #RareDiseaseCommunity #SupportNetwork #AlportUK
What is RaDaR?
Are you registered?
RaDaR tracks data on 1200+ Alport patients in the UK to boost kidney research.
Join to improve Alport diagnosis & treatments!
Register via your consultant!
More info: www.ukkidney.org/rare-renal/a...
#AlportSyndrome #RaDaR
Are you registered?
RaDaR tracks data on 1200+ Alport patients in the UK to boost kidney research.
Join to improve Alport diagnosis & treatments!
Register via your consultant!
More info: www.ukkidney.org/rare-renal/a...
#AlportSyndrome #RaDaR
July 7, 2025 at 1:01 PM
What is RaDaR?
Are you registered?
RaDaR tracks data on 1200+ Alport patients in the UK to boost kidney research.
Join to improve Alport diagnosis & treatments!
Register via your consultant!
More info: www.ukkidney.org/rare-renal/a...
#AlportSyndrome #RaDaR
Are you registered?
RaDaR tracks data on 1200+ Alport patients in the UK to boost kidney research.
Join to improve Alport diagnosis & treatments!
Register via your consultant!
More info: www.ukkidney.org/rare-renal/a...
#AlportSyndrome #RaDaR
🎥 New RaDaR data on #AlportSyndrome
✅ 1175 patients
✅Key for understanding disease progression
✅ Informs future trial design
RaDaR's Danny Gale discusses the most detailed AS analysis yet.
🎥Watch the HCP Live News interview: ow.ly/xo7150WbFcY
#RareKidneyDisease
✅ 1175 patients
✅Key for understanding disease progression
✅ Informs future trial design
RaDaR's Danny Gale discusses the most detailed AS analysis yet.
🎥Watch the HCP Live News interview: ow.ly/xo7150WbFcY
#RareKidneyDisease
Alport Syndrome Outcomes Linked to Genotype and Proteinuria in RaDaR Study
A RaDaR analysis from ERA 2025 provides insight into predictors of disease progression, outcomes in patients with Alport syndrome.
ow.ly
July 1, 2025 at 4:00 PM
🎥 New RaDaR data on #AlportSyndrome
✅ 1175 patients
✅Key for understanding disease progression
✅ Informs future trial design
RaDaR's Danny Gale discusses the most detailed AS analysis yet.
🎥Watch the HCP Live News interview: ow.ly/xo7150WbFcY
#RareKidneyDisease
✅ 1175 patients
✅Key for understanding disease progression
✅ Informs future trial design
RaDaR's Danny Gale discusses the most detailed AS analysis yet.
🎥Watch the HCP Live News interview: ow.ly/xo7150WbFcY
#RareKidneyDisease
Chemical chaperone 4-phenylbutyrate treatment alleviates the kidney phenotype in a mouse model of Alport syndrome with a pathogenic variant in Col4a3
doi.org/10.1016/j.kint.2025.05.016
#MedSky #NephSky #OpenAccess #ckd #chronickidneydisease #alportsyndrome
doi.org/10.1016/j.kint.2025.05.016
#MedSky #NephSky #OpenAccess #ckd #chronickidneydisease #alportsyndrome
June 9, 2025 at 11:35 AM
Chemical chaperone 4-phenylbutyrate treatment alleviates the kidney phenotype in a mouse model of Alport syndrome with a pathogenic variant in Col4a3
doi.org/10.1016/j.kint.2025.05.016
#MedSky #NephSky #OpenAccess #ckd #chronickidneydisease #alportsyndrome
doi.org/10.1016/j.kint.2025.05.016
#MedSky #NephSky #OpenAccess #ckd #chronickidneydisease #alportsyndrome
🌈 Alport UK celebrates #PrideMonth! 🌈
Everyone with Alport Syndrome deserves to be recognized for who they are, whether LGBTQIA+ or an ally.
Let's build a world where everyone feels seen & supported! 💖
#InclusiveCommunity #KidneyPride #RareAndProud #AlportSyndrome
Everyone with Alport Syndrome deserves to be recognized for who they are, whether LGBTQIA+ or an ally.
Let's build a world where everyone feels seen & supported! 💖
#InclusiveCommunity #KidneyPride #RareAndProud #AlportSyndrome
June 4, 2025 at 8:10 AM
🌈 Alport UK celebrates #PrideMonth! 🌈
Everyone with Alport Syndrome deserves to be recognized for who they are, whether LGBTQIA+ or an ally.
Let's build a world where everyone feels seen & supported! 💖
#InclusiveCommunity #KidneyPride #RareAndProud #AlportSyndrome
Everyone with Alport Syndrome deserves to be recognized for who they are, whether LGBTQIA+ or an ally.
Let's build a world where everyone feels seen & supported! 💖
#InclusiveCommunity #KidneyPride #RareAndProud #AlportSyndrome
Thank you to Florence Nightingale for changing the path for a brighter future for nursing and to all our nurses who help create a brighter future for people living with Alport Syndrome.
#florencenightingale #renalnurses #dialysisnurses #transplantnurses #changes #alportsyndrome
#florencenightingale #renalnurses #dialysisnurses #transplantnurses #changes #alportsyndrome
May 13, 2025 at 12:35 PM
Thank you to Florence Nightingale for changing the path for a brighter future for nursing and to all our nurses who help create a brighter future for people living with Alport Syndrome.
#florencenightingale #renalnurses #dialysisnurses #transplantnurses #changes #alportsyndrome
#florencenightingale #renalnurses #dialysisnurses #transplantnurses #changes #alportsyndrome
#LegacyContent: PDGF-D is dispensable for the development and progression of murine #Alportsyndrome. Authors from
@rwth.bsky.social, @radboudumc.bsky.social, and @ki.se.
Free in the #OpenArchive: ajp.amjpathol.org/article/S000...
@rwth.bsky.social, @radboudumc.bsky.social, and @ki.se.
Free in the #OpenArchive: ajp.amjpathol.org/article/S000...
PDGF-D Is Dispensable for the Development and Progression of Murine Alport Syndrome
Alport syndrome is an inherited kidney disease, which can lead to glomerulosclerosis
and fibrosis, as well as end-stage kidney disease in children and adults. Platelet-derived
growth factor-D (PDGF-D)...
ajp.amjpathol.org
May 7, 2025 at 4:52 PM
#LegacyContent: PDGF-D is dispensable for the development and progression of murine #Alportsyndrome. Authors from
@rwth.bsky.social, @radboudumc.bsky.social, and @ki.se.
Free in the #OpenArchive: ajp.amjpathol.org/article/S000...
@rwth.bsky.social, @radboudumc.bsky.social, and @ki.se.
Free in the #OpenArchive: ajp.amjpathol.org/article/S000...
The real one had something called #AlportSyndrome I think.
April 27, 2025 at 4:27 PM
The real one had something called #AlportSyndrome I think.
📘 New 2024 guideline on Alport syndrome just published in NDT by ERKNet, ERA & ESPN — covering diagnosis, management & treatment.
Read the abstract: academic.oup.com/ndt/advance-...
#AlportSyndrome #Nephrology #RareDisease #Guidelines
Read the abstract: academic.oup.com/ndt/advance-...
#AlportSyndrome #Nephrology #RareDisease #Guidelines
April 8, 2025 at 10:50 AM
📘 New 2024 guideline on Alport syndrome just published in NDT by ERKNet, ERA & ESPN — covering diagnosis, management & treatment.
Read the abstract: academic.oup.com/ndt/advance-...
#AlportSyndrome #Nephrology #RareDisease #Guidelines
Read the abstract: academic.oup.com/ndt/advance-...
#AlportSyndrome #Nephrology #RareDisease #Guidelines
Congratulations to Professor Kai at #KumamotoUniversity for bringing together the #AlportSyndrome community in Japan to advance efforts in awareness, early diagnosis and therapeutic development. I was honoured to be a small part of it.
March 31, 2025 at 1:34 PM
Congratulations to Professor Kai at #KumamotoUniversity for bringing together the #AlportSyndrome community in Japan to advance efforts in awareness, early diagnosis and therapeutic development. I was honoured to be a small part of it.